56 Views | 28 Downloads
Elisabeth P. Dellon, MD, MPH, Division of Pulmonology, Department of Pediatrics, UNC School of Medicine, CB #7217, 450 MacNider Hall, 333 South Columbia Street, Chapel Hill, NC 27599-7217. Email: elisabeth_dellon@med.unc.edu
The authors would like to thank the Cystic Fibrosis Foundation for facilitating this study through care team listservs and Community Voice. We are particularly grateful to adults with CF and CF family members across the United States for sharing their insights through Community Voice. This study was supported by the Cystic Fibrosis Foundation (DELLON16QI10) and the National Heart, Lung, and Blood Institute (K01HL133466).
EPD receives research funding from the Cystic Fibrosis Foundation; AMG receives research funding from the Cystic Fibrosis Foundation and has served as a consultant to Vertex Pharmaceuticals, Inc; CHG receives research funding from the Cystic Fibrosis Foundation, the National Institutes of Health, the Food and Drug Administration, and Boehringer Ingeleheim, and has received honoraria from Gilead Sciences, Novartis, the European Commission; SEH and AF are employed by the Cystic Fibrosis Foundation; DK receives research funding from the Cystic Fibrosis Foundation, National Institutes of Health, and the Milbank Foundation; ET, MB, MRH, EC, JG have no conflicts of interest to report.
National Heart, Lung, and Blood Institute, Grant/Award Number: K01HL133466; Cystic Fibrosis Foundation, Grant/Award Number: DELLON16QI10